168 related articles for article (PubMed ID: 15047743)
1. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.
Bulk S; Van Kemenade FJ; Rozendaal L; Meijer CJ
J Clin Pathol; 2004 Apr; 57(4):388-93. PubMed ID: 15047743
[TBL] [Abstract][Full Text] [Related]
2. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
3. Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.
Prinsen CF; Fles R; Wijnen-Dubbers CW; de Valk HA; Klaassen CH; Mravunac M; Horrevorts AM; Thunnissen FB
BJOG; 2007 Aug; 114(8):951-7. PubMed ID: 17578475
[TBL] [Abstract][Full Text] [Related]
4. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
5. Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands.
Siebers AG; Massuger LF; Bulten J
Cytopathology; 2007 Apr; 18(2):96-104. PubMed ID: 17397494
[TBL] [Abstract][Full Text] [Related]
6. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
7. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
9. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
10. The development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the English NHS cervical screening programme--is there an optimum level of detection of CIN 1 and CIN 2 lesions?
Blanks RG
Cytopathology; 2008 Aug; 19(4):244-53. PubMed ID: 18476989
[TBL] [Abstract][Full Text] [Related]
11. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
12. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
13. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
[TBL] [Abstract][Full Text] [Related]
14. Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme.
Haldorsen T; Skare GB; Ursin G; Bjørge T
Acta Oncol; 2015 Feb; 54(2):200-9. PubMed ID: 24957553
[TBL] [Abstract][Full Text] [Related]
15. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
16. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study.
Siebers AG; Arbyn M; Melchers WJ; van Kemenade FJ; Vedder JE; van der Linden H; van Ballegooijen M; Bekkers RL; Bulten J
Cancer Causes Control; 2014 Sep; 25(9):1141-9. PubMed ID: 24935226
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
[TBL] [Abstract][Full Text] [Related]
19. [Previous screening for cervical cancer among women with cytological and histological abnormalities].
Rama C; Roteli-Martins C; Derchain S; Longatto-Filho A; Gontijo R; Sarian L; Syrjanen K; Ching T; Aldrighi J
Rev Saude Publica; 2008 Jun; 42(3):411-9. PubMed ID: 18470363
[TBL] [Abstract][Full Text] [Related]
20. Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology.
Massad SL; Markwell S; Cejtin HE; Collins Y
J Low Genit Tract Dis; 2005 Oct; 9(4):225-9. PubMed ID: 16205193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
